Inventor
GAJEWSKI THOMAS
US6 patents
⚠️ This page may combine multiple inventors who share the name “GAJEWSKI THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
3 patentsUS5851523ADec 22, 1998
Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
LUDWIG INST CANCER RES20 citations91
US5591430AJan 7, 1997
Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
LUDWIG INST CANCER RES35 citations91
US6682731B1Jan 27, 2004
Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules
LUDWIG INST CANCER RES3 citations58
UNIV CHICAGO
3 patentsUS11946936B2Apr 2, 2024
Beta-catenin inhibitors in cancer immunotherapy
UNIV CHICAGO0 citations58
US10753938B2Aug 25, 2020
Beta-catenin inhibitors in cancer immunotherapy
UNIV CHICAGO1 citations58
US11566077B2Jan 31, 2023
Dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment
UNIV CHICAGO0 citations55